Myasthenia gravis is an autoimmune disorder causing muscle weakness and fatigability due to antibodies interfering with signal transmission at the neuromuscular junction. It is classified based on severity and affected muscle groups. Symptoms include drooping eyelids and difficulties with eye movement, facial expression, swallowing, talking and breathing. The condition occurs when antibodies disrupt acetylcholine receptor signaling, commonly due to thymic abnormalities. Diagnosis involves physical exams, blood tests, imaging and response to medication. Treatment includes acetylcholinesterase inhibitors, immunosuppressants, plasmapheresis and sometimes thymectomy.